Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Behjatolah Karbassi

Concepts (272)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Tumor-Associated, Carbohydrate
15
2023
24
3.930
Why?
Cancer Vaccines
13
2022
78
2.680
Why?
Peptides
17
2022
223
2.620
Why?
Carbohydrates
14
2009
40
2.430
Why?
Molecular Mimicry
13
2007
38
2.060
Why?
Breast Neoplasms
12
2024
1174
1.750
Why?
Neoplasms
9
2022
1235
1.520
Why?
Immunotherapy
6
2022
238
1.130
Why?
Epitopes, T-Lymphocyte
6
2009
24
0.920
Why?
HIV Envelope Protein gp120
4
2009
9
0.860
Why?
Lung Neoplasms
4
2014
606
0.840
Why?
Antibodies, Neoplasm
2
2017
28
0.830
Why?
HIV-1
4
2009
55
0.830
Why?
Mice, Inbred BALB C
16
2011
304
0.810
Why?
Antigens
4
2003
41
0.790
Why?
Animals
31
2023
13187
0.680
Why?
Epithelial-Mesenchymal Transition
2
2020
47
0.670
Why?
Clinical Trials, Phase I as Topic
2
2017
25
0.640
Why?
Gene Expression Regulation, Neoplastic
5
2020
828
0.630
Why?
Vaccines, DNA
6
2006
11
0.630
Why?
Immunologic Surveillance
2
2009
10
0.620
Why?
HIV Antigens
3
2006
9
0.600
Why?
Epitopes
3
2009
59
0.590
Why?
Cell Transformation, Neoplastic
1
2018
177
0.580
Why?
Antineoplastic Agents
3
2017
1171
0.550
Why?
Immunity, Innate
3
2018
104
0.550
Why?
Molecular Targeted Therapy
1
2017
119
0.530
Why?
Neoplasm Proteins
1
2018
322
0.530
Why?
Mice
20
2011
5739
0.520
Why?
Biomimetic Materials
1
2014
9
0.490
Why?
Cell Hypoxia
1
2015
82
0.490
Why?
Epigenesis, Genetic
1
2018
374
0.490
Why?
Estrogen Receptor alpha
1
2015
89
0.480
Why?
Vaccines
4
2002
50
0.460
Why?
T-Lymphocytes
7
2010
338
0.450
Why?
Cross Reactions
8
2006
42
0.450
Why?
Oligosaccharides
4
2007
33
0.450
Why?
Amino Acid Sequence
9
2006
585
0.440
Why?
Sarcoma, Experimental
2
2004
13
0.440
Why?
Molecular Sequence Data
9
2006
792
0.440
Why?
Polysaccharides
2
2011
50
0.430
Why?
Antigens, Neoplasm
5
2007
151
0.430
Why?
Humans
35
2024
49974
0.430
Why?
AIDS Vaccines
3
2009
8
0.410
Why?
Plant Lectins
2
2010
8
0.410
Why?
Isoflavones
1
2023
89
0.410
Why?
Sulfotransferases
3
2020
40
0.400
Why?
Chondroitin Sulfates
2
2011
13
0.390
Why?
P-Selectin
2
2011
32
0.380
Why?
Soybean Proteins
1
2023
161
0.380
Why?
CD8-Positive T-Lymphocytes
3
2007
116
0.380
Why?
Fructose
1
2010
23
0.370
Why?
Autoantigens
1
2011
58
0.370
Why?
Carbon
1
2010
54
0.360
Why?
Adaptive Immunity
1
2010
32
0.360
Why?
Vaccines, Subunit
3
2006
15
0.340
Why?
CD4-Positive T-Lymphocytes
3
2006
164
0.340
Why?
Obesity
2
2023
1113
0.340
Why?
Drug Delivery Systems
1
2010
138
0.320
Why?
Carcinoma, Ductal
1
2008
9
0.320
Why?
Proteoglycans
3
2023
80
0.310
Why?
Mammary Neoplasms, Experimental
2
2005
122
0.300
Why?
Interferon-gamma
4
2018
177
0.300
Why?
Carcinoma in Situ
1
2008
73
0.300
Why?
Cell Line, Tumor
6
2011
1403
0.290
Why?
Dendritic Cells
3
2005
133
0.280
Why?
T-Lymphocytes, Cytotoxic
5
2009
65
0.280
Why?
Female
18
2024
26472
0.280
Why?
Concanavalin A
2
2005
11
0.260
Why?
HIV Infections
1
2009
357
0.260
Why?
Sarcoma
1
2006
67
0.260
Why?
Mammary Neoplasms, Animal
1
2005
35
0.250
Why?
Ligands
5
2011
204
0.250
Why?
MCF-7 Cells
4
2020
68
0.250
Why?
Neoplasm Metastasis
5
2015
231
0.240
Why?
Magnetic Resonance Spectroscopy
1
2005
244
0.240
Why?
Acetylglucosamine
1
2004
6
0.240
Why?
Histocompatibility Antigens Class I
1
2004
44
0.230
Why?
Combined Modality Therapy
2
2017
637
0.230
Why?
Immunoglobulin G
2
2003
186
0.230
Why?
Immunotherapy, Active
1
2003
4
0.220
Why?
Melanoma
1
2007
285
0.220
Why?
Peptide Fragments
1
2004
215
0.220
Why?
Peptide Library
4
2005
16
0.220
Why?
Autoantibodies
2
2018
116
0.210
Why?
Glycosylation
3
2010
100
0.210
Why?
Cell Proliferation
4
2020
1007
0.210
Why?
Antigens, Viral
1
2002
44
0.200
Why?
Apoptosis
2
2020
1101
0.200
Why?
Antibodies, Monoclonal
5
2023
459
0.200
Why?
Biochemistry
1
2001
5
0.200
Why?
Liver Neoplasms
1
2005
326
0.190
Why?
Enzyme-Linked Immunosorbent Assay
3
2010
244
0.190
Why?
Cell Adhesion
3
2006
158
0.180
Why?
CHO Cells
3
2006
120
0.180
Why?
Carbamates
1
2020
16
0.180
Why?
Cricetinae
3
2006
192
0.180
Why?
Adjuvants, Immunologic
2
2014
51
0.180
Why?
Colchicine
1
2020
28
0.180
Why?
Antineoplastic Agents, Phytogenic
1
2020
69
0.170
Why?
Carcinoma, Ductal, Breast
1
2020
89
0.170
Why?
Neoplastic Stem Cells
1
2020
103
0.170
Why?
Tumor Microenvironment
2
2024
212
0.160
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2020
92
0.160
Why?
Anthroposophy
1
2018
1
0.160
Why?
Tumor Cells, Cultured
3
2015
465
0.160
Why?
Antibody Formation
3
2003
54
0.160
Why?
Gene-Environment Interaction
1
2018
36
0.160
Why?
Cell Division
3
2006
292
0.160
Why?
Immunization
3
2004
67
0.150
Why?
Chondroitin Sulfate Proteoglycans
2
2023
18
0.150
Why?
Immune Tolerance
2
2009
96
0.150
Why?
Plant Extracts
1
2020
190
0.150
Why?
Cell Movement
4
2020
247
0.150
Why?
Flow Cytometry
3
2006
476
0.150
Why?
Spleen
3
2004
172
0.150
Why?
Homeostasis
1
2018
200
0.140
Why?
Clinical Trials, Phase II as Topic
1
2017
43
0.140
Why?
Forecasting
1
2017
150
0.130
Why?
HIV Antibodies
2
2006
10
0.130
Why?
Models, Immunological
2
2007
8
0.130
Why?
Membrane Proteins
2
2023
341
0.130
Why?
Phenotype
2
2010
729
0.130
Why?
Lectins
2
2006
14
0.130
Why?
Interleukin-12
2
2006
31
0.130
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2015
56
0.120
Why?
Coculture Techniques
1
2015
146
0.120
Why?
Drug Therapy
1
2014
46
0.120
Why?
Transforming Growth Factor beta
1
2015
144
0.120
Why?
Antibodies
1
2014
154
0.120
Why?
Adipocytes
1
2015
121
0.120
Why?
Vaccines, Conjugate
2
2005
8
0.110
Why?
Nuclear Proteins
1
2015
242
0.110
Why?
Cell Separation
2
2005
89
0.110
Why?
Rats, Zucker
1
2023
69
0.110
Why?
Scavenger Receptors, Class E
1
2015
204
0.110
Why?
Positron-Emission Tomography
1
2014
295
0.110
Why?
Cytotoxicity, Immunologic
2
2005
54
0.110
Why?
Protein Binding
2
2005
660
0.100
Why?
Mutation
1
2018
1294
0.100
Why?
Immunity, Cellular
2
2003
69
0.100
Why?
Mice, Nude
2
2004
252
0.100
Why?
C-Reactive Protein
1
2023
142
0.100
Why?
Lymphocyte Activation
3
2001
172
0.100
Why?
Kinetics
2
2005
623
0.100
Why?
Injections, Intramuscular
2
2003
54
0.100
Why?
Interleukin-6
1
2023
264
0.100
Why?
Binding Sites
2
2003
374
0.100
Why?
Prognosis
3
2020
1942
0.100
Why?
Tumor Necrosis Factor-alpha
1
2023
388
0.090
Why?
Lung
1
2014
486
0.090
Why?
Microscopy, Phase-Contrast
1
2010
11
0.090
Why?
Body Weight
1
2023
513
0.090
Why?
B-Lymphocytes
2
2002
170
0.090
Why?
DNA Methylation
1
2015
548
0.090
Why?
Transfection
3
2007
354
0.090
Why?
Substrate Specificity
1
2010
194
0.090
Why?
Antigens, CD
2
2003
219
0.090
Why?
Membrane Glycoproteins
2
2003
240
0.090
Why?
Actins
1
2010
118
0.090
Why?
Antibodies, Catalytic
1
2009
1
0.090
Why?
Receptors, CCR5
1
2009
6
0.090
Why?
Dose-Response Relationship, Drug
2
2005
1376
0.090
Why?
Neoplasm Invasiveness
1
2010
267
0.090
Why?
Cells, Cultured
2
2003
1573
0.080
Why?
Time Factors
2
2005
2903
0.080
Why?
Killer Cells, Natural
1
2009
95
0.080
Why?
Male
3
2023
25241
0.070
Why?
Fucosyltransferases
1
2007
5
0.070
Why?
Glycosaminoglycans
1
2007
19
0.070
Why?
Molecular Biology
1
2007
25
0.070
Why?
Binding Sites, Antibody
1
2006
15
0.070
Why?
Amino Acid Motifs
1
2006
56
0.070
Why?
Cricetulus
1
2006
97
0.070
Why?
Rats
1
2023
3305
0.070
Why?
Heparin
1
2007
92
0.070
Why?
Antineoplastic Agents, Alkylating
1
2006
74
0.070
Why?
E-Selectin
1
2005
15
0.070
Why?
Cell Membrane
1
2007
248
0.070
Why?
Xenograft Model Antitumor Assays
1
2006
211
0.070
Why?
Hydrocarbons
1
2005
5
0.070
Why?
Phosphorylcholine
1
2005
13
0.070
Why?
Densitometry
1
2005
11
0.060
Why?
Mannose
1
2005
16
0.060
Why?
Cyclophosphamide
1
2006
165
0.060
Why?
Wheat Germ Agglutinins
1
2005
3
0.060
Why?
Methane
1
2005
7
0.060
Why?
Surface Plasmon Resonance
1
2005
22
0.060
Why?
Bone Marrow Cells
1
2006
191
0.060
Why?
Biosensing Techniques
1
2005
25
0.060
Why?
Growth Inhibitors
1
2005
27
0.060
Why?
Calcium
1
2007
396
0.060
Why?
Glycolysis
1
2005
70
0.060
Why?
Genetic Variation
1
2006
213
0.060
Why?
Immunoglobulins
1
2005
79
0.060
Why?
Oligonucleotide Array Sequence Analysis
1
2006
411
0.060
Why?
Antigen Presentation
1
2004
25
0.060
Why?
Endothelial Cells
1
2006
269
0.060
Why?
Bone Neoplasms
1
2006
179
0.060
Why?
Treatment Outcome
1
2014
5141
0.060
Why?
Cytosol
1
2004
82
0.060
Why?
Middle Aged
2
2020
12069
0.060
Why?
Immunoglobulin Constant Regions
1
2003
2
0.060
Why?
Plasmids
2
2003
161
0.060
Why?
Recombinant Proteins
1
2005
486
0.060
Why?
Antibodies, Viral
1
2003
88
0.060
Why?
Histocompatibility Antigens Class II
1
2003
37
0.060
Why?
Immunoglobulin M
1
2003
52
0.050
Why?
Bacterial Capsules
1
2003
18
0.050
Why?
Th1 Cells
1
2003
52
0.050
Why?
DNA, Neoplasm
1
2003
147
0.050
Why?
Carbohydrate Metabolism
1
2002
26
0.050
Why?
Antibodies, Anti-Idiotypic
1
2002
19
0.050
Why?
Models, Chemical
1
2002
66
0.050
Why?
L-Selectin
1
2001
7
0.050
Why?
Calorimetry
1
2001
6
0.050
Why?
Carbohydrate Sequence
1
2001
11
0.050
Why?
Epitope Mapping
1
2001
6
0.050
Why?
Thermodynamics
1
2001
34
0.050
Why?
Binding, Competitive
1
2001
94
0.050
Why?
Mice, Inbred CBA
1
2001
35
0.050
Why?
Protein Structure, Secondary
1
2001
72
0.050
Why?
Gene Expression Profiling
1
2006
1032
0.050
Why?
Sequence Homology, Amino Acid
1
2001
144
0.050
Why?
Protein Conformation
1
2001
166
0.050
Why?
Antibody-Dependent Cell Cytotoxicity
1
2000
12
0.050
Why?
Injections, Intraperitoneal
1
2000
54
0.050
Why?
Colchicum
1
2020
4
0.050
Why?
Inhibitory Concentration 50
1
2020
76
0.040
Why?
Models, Molecular
1
2001
338
0.040
Why?
Drug Screening Assays, Antitumor
1
2020
136
0.040
Why?
Child, Preschool
1
2008
3871
0.040
Why?
Wnt Signaling Pathway
1
2020
92
0.040
Why?
H-2 Antigens
1
1999
4
0.040
Why?
Receptors, Estrogen
1
2020
130
0.040
Why?
Transformation, Genetic
1
1998
16
0.040
Why?
Clostridium
1
1998
15
0.040
Why?
Glycoside Hydrolases
1
1998
17
0.040
Why?
Cell Survival
1
2020
600
0.040
Why?
Plants
1
1998
27
0.040
Why?
Genes, Reporter
1
1998
89
0.040
Why?
Models, Biological
1
2001
727
0.040
Why?
Survival Rate
1
2020
894
0.040
Why?
Adolescent
1
2008
6356
0.040
Why?
Retrospective Studies
1
2008
6108
0.030
Why?
Child
1
2008
6847
0.030
Why?
CpG Islands
1
2015
108
0.030
Why?
Disease Progression
1
2015
825
0.030
Why?
RNA Interference
1
2011
179
0.020
Why?
RNA, Small Interfering
1
2011
215
0.020
Why?
Simian virus 40
1
2003
12
0.010
Why?
Lymphocyte Subsets
1
2003
13
0.010
Why?
Immunoglobulin Variable Region
1
2003
13
0.010
Why?
Mutagenesis, Site-Directed
1
2003
99
0.010
Why?
Sequence Deletion
1
2003
66
0.010
Why?
Protein Structure, Tertiary
1
2003
253
0.010
Why?
Recombinant Fusion Proteins
1
2003
181
0.010
Why?
Down-Regulation
1
2003
348
0.010
Why?
Up-Regulation
1
2003
452
0.010
Why?
Radiation Chimera
1
1999
3
0.010
Why?
HIV Envelope Protein gp160
1
1999
2
0.010
Why?
beta 2-Microglobulin
1
1999
38
0.010
Why?
Protein Engineering
1
1999
18
0.010
Why?
Plants, Toxic
1
1998
10
0.010
Why?
Enzyme Stability
1
1998
20
0.010
Why?
Plants, Genetically Modified
1
1998
22
0.010
Why?
Stem Cells
1
1999
171
0.010
Why?
Hot Temperature
1
1998
207
0.010
Why?
Signal Transduction
1
2003
1618
0.010
Why?
Mice, Knockout
1
1999
841
0.010
Why?
Mice, Inbred C57BL
1
1999
1816
0.010
Why?
Muscle, Skeletal
1
1999
750
0.010
Why?
Karbassi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description